Skip to main content
logo
Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.05725
+0.000585 (1.03%)
At close: Aug 18, 2026

PVCT Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.060.340.620.560.99-
Revenue Growth
-91.26%-45.54%10.66%-43.61%--
Gross Profit
-1.68-1.48-1.34-1.14-1.32-2.52
Operating Income
-4.99-4.84-3.95-2.5-2.87-4.64
Net Income
-5.58-5.43-4.73-3.1-3.55-5.54
Earnings Per Share
-0.01-0.01-0.01-0.01-0.01-0.01
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.220.250.310.080.020.68
Total Debt
2.772.983.183.032.181.74
Net Cash (Debt)
-2.54-2.73-2.88-2.95-2.16-1.06
Net Cash Growth
------
Net Cash Per Share
-0.01-0.01-0.01-0.01-0.01-0.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.59-3.33-3.28-2.57-3.04-1.01
Capital Expenditures
------
Free Cash Flow
-2.59-3.33-3.28-2.57-3.04-1.01
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---216.87%-204.69%-133.60%-
Operating Margin
-8688.64%-1441.28%-639.43%-447.97%-290.12%-
Pretax Margin
-9819.89%-1637.90%-771.65%-556.16%-359.41%-
Profit Margin
-9709.81%-1615.80%-766.85%-556.16%-359.41%-
FCF Margin
-4506.11%-989.56%-532.15%-461.17%-307.52%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-69.9081.7972.2145.94-